Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
25%
Ph phase_2
3
75%

Phase Distribution

0

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
3(75.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

33.3%

1 of 3 finished

Non-Completion Rate

66.7%

2 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(1)
Terminated(2)

Detailed Status

Withdrawn2
Not yet recruiting1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 23 (75.0%)
N/A1 (25.0%)

Trials by Status

not_yet_recruiting125%
completed125%
withdrawn250%

Recent Activity

0 active trials
Showing 4 of 4
not_yet_recruitingphase_2

Effects of Pharmacological Stress and rTMS on Executive Function in Opioid Use Disorder

NCT04231708
withdrawnphase_2

Using rTMS to Explore Neural Mechanisms of Stress-Induced Opioid Use

NCT04181515
withdrawnphase_2

rTMS of Limbic Circuitry in Stress Modulation in Healthy Volunteers

NCT04180969
completednot_applicable

The Role of Stress Neuromodulators in Decision Making Under Risk and Selective Attention to Threat

NCT04359147

Clinical Trials (4)

Showing 4 of 4 trials
NCT04231708Phase 2

Effects of Pharmacological Stress and rTMS on Executive Function in Opioid Use Disorder

Not Yet Recruiting
NCT04181515Phase 2

Using rTMS to Explore Neural Mechanisms of Stress-Induced Opioid Use

Withdrawn
NCT04180969Phase 2

rTMS of Limbic Circuitry in Stress Modulation in Healthy Volunteers

Withdrawn
NCT04359147Not Applicable

The Role of Stress Neuromodulators in Decision Making Under Risk and Selective Attention to Threat

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4